UPSC MainsGENERAL-STUDIES-PAPER-III201310 Marks200 Words
Q15.

What do you understand by Fixed Dose Drug Combinations (FDCs) ? Discuss their merits and demerits.

How to Approach

This question requires a balanced discussion of Fixed Dose Drug Combinations (FDCs). The approach should begin with defining FDCs, then systematically outlining their advantages and disadvantages. Focus on the Indian context, referencing relevant regulations and controversies. Structure the answer into introduction, merits, demerits, and conclusion. Include examples of commonly used FDCs and the regulatory bodies involved. The answer should demonstrate an understanding of both the pharmaceutical and public health aspects of the issue.

Model Answer

0 min read

Introduction

Fixed Dose Drug Combinations (FDCs) are single pharmaceutical preparations containing two or more active pharmaceutical ingredients (APIs) in a fixed ratio. They are widely used in India, particularly for common ailments like cold, fever, and hypertension, offering convenience and potentially lower costs. However, the widespread use of FDCs in India has been a subject of debate and regulatory scrutiny, with concerns raised about their efficacy, safety, and rational use. The recent ban on over 300 FDCs by the Indian government in 2018 highlights the complexities surrounding their regulation and use.

Merits of Fixed Dose Drug Combinations (FDCs)

FDCs offer several potential benefits:

  • Improved Patient Compliance: Combining multiple drugs into a single pill simplifies the medication regimen, increasing adherence, especially for patients with complex treatment plans.
  • Reduced Pill Burden: Fewer pills to take reduces the psychological burden on patients, particularly the elderly or those with chronic conditions.
  • Potential Cost Savings: In some cases, FDCs can be more cost-effective than taking individual medications separately, although this isn’t always the case.
  • Synergistic Effects: Combining drugs with complementary mechanisms of action can lead to enhanced therapeutic effects. For example, combining an antibiotic with a beta-lactamase inhibitor.
  • Convenience: FDCs are convenient for both patients and healthcare providers, simplifying prescription and administration.

Demerits of Fixed Dose Drug Combinations (FDCs)

Despite the advantages, FDCs also have significant drawbacks:

  • Irrational Combinations: A major concern is the prevalence of irrational FDCs, particularly in India, where many combinations lack scientific justification and clinical evidence of benefit.
  • Adverse Drug Reactions (ADRs): Combining drugs increases the risk of ADRs and drug-drug interactions, potentially leading to serious health consequences.
  • Antibiotic Resistance: The indiscriminate use of FDCs containing antibiotics contributes to the growing problem of antimicrobial resistance.
  • Difficulty in Dose Adjustment: Adjusting the dosage of individual components within an FDC can be challenging, potentially leading to under- or over-treatment.
  • Masking of Symptoms: FDCs containing analgesics and antipyretics can mask underlying symptoms, delaying accurate diagnosis and treatment.
  • Regulatory Challenges: Regulating FDCs is complex, requiring rigorous evaluation of each combination's safety and efficacy.

Regulatory Landscape in India

The regulation of FDCs in India is primarily governed by the Drugs and Cosmetics Act, 1940 and Rules, 1945. The Central Drugs Standard Control Organization (CDSCO) is the apex regulatory body. In 2018, the government banned over 300 FDCs deemed irrational or harmful, following a report by the Kokate Committee (2014). However, the implementation of this ban has faced legal challenges and ongoing debates.

Regulatory Body Role
CDSCO Apex regulatory body for drugs and cosmetics in India.
Kokate Committee Expert committee formed to review FDCs and recommend bans.
State Drug Controllers Responsible for enforcing drug regulations at the state level.

Examples of FDCs

Commonly used FDCs include:

  • Amoxicillin + Clavulanic Acid (antibiotic combination)
  • Paracetamol + Dicyclomine (pain reliever + antispasmodic)
  • Lisinopril + Hydrochlorothiazide (antihypertensive combination)

Conclusion

FDCs present a complex dilemma. While offering potential benefits in terms of convenience and compliance, their widespread and often unregulated use, particularly in India, poses significant risks to public health. Strengthening regulatory oversight, promoting rational drug use, and prioritizing evidence-based medicine are crucial steps to ensure that FDCs are used safely and effectively. A balanced approach that encourages innovation while safeguarding patient interests is essential for harnessing the potential of FDCs while mitigating their risks.

Answer Length

This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.

Additional Resources

Key Definitions

API
Active Pharmaceutical Ingredient: The component in a drug that produces its effects.
Rational Drug Use
Rational drug use means that patients receive medications appropriate to their clinical needs, in doses that are effective, for an adequate duration, and at the lowest cost to them and the community.

Key Statistics

India is the largest producer of generic drugs globally, accounting for approximately 20% of the world’s export volume.

Source: Indian Brand Equity Foundation (IBEF), 2023 (Knowledge Cutoff)

Approximately 30% of all drugs sold in India are FDCs, a significantly higher proportion than in most other countries.

Source: WHO Report on the Quality of Medicines, 2018 (Knowledge Cutoff)

Examples

The 2018 FDC Ban

In March 2018, the Indian government banned over 300 FDCs following a Supreme Court order, citing a lack of evidence of efficacy and safety. This ban included combinations commonly used for respiratory infections and pain relief.

Frequently Asked Questions

Are all FDCs harmful?

No, not all FDCs are harmful. Some combinations are scientifically justified and offer clinical benefits. However, a significant proportion of FDCs, particularly in India, are irrational and potentially harmful.

Topics Covered

Science & TechnologyHealthPharmaceuticalsHealthcareMedicineDrug Regulation